U.S. Patent
BIO 2017
National Cancer Conference
Cancer Research News- One Year Anniversary of Cancer Moonshot Reignition Brings Progress and Opportunity February 3, 2023American Cancer Society and ACS CAN Continue Commitment to End Cancer As We Know It, For Everyone
- American Cancer Society’s BrightEdge Receives $1.25 Million Grant from WoodNext Foundation to Launch Entrepreneurship Fellows Program February 1, 2023Program to support and fund scientific founders and their early-stage companies among American Cancer Society-affiliated postdoctoral and early career researchers
- Suicide Risk Higher Among Individuals with Cancer, New Study Shows January 20, 2023
- American Cancer Society Releases Latest Cancer Statistics, Launches Initiative to Address Prostate Cancer Resurgence and Disparities January 12, 2023
- La Sociedad Americana Contra El Cáncer publica las últimas estadísticas sobre el cáncer, lanza una iniciativa para abordar la recurrencia y las inequidades del cáncer de próstata January 12, 2023
- One Year Anniversary of Cancer Moonshot Reignition Brings Progress and Opportunity February 3, 2023
Health Care Forum “War on Cancer” (March 30th 2017-Singapore)
Author Archives: czbiomed_t0k2xz
Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment
Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment Well Marker Bio Co. Ltd., a biotech division of Asan Medical Center of South Korea, signs Memorandum of Understanding with CZ Biomed Corp. and Kocal … Continue reading
Posted in Uncategorized
Leave a comment
Partnerships with Bio-pharmaceutical Leaders
Kocal Consulting Corporation Celebrates new Consulting Agreement with CZ Biomed Corp to Help Deliver Real Value to Bio-pharmaceutical World Bio-pharmaceutical insiders have long known about the important, diverse work being done by CZ Biomed Corp, some of which could have … Continue reading
Posted in Cancer News, Colon Cancer, Prostate Cancer
Leave a comment
Oncolytic Virus Reduces Prostate Cancer
Oncolytic Virus Genetically Engineered from “Respiratory Syncytial Virus” (RSV) Reduces Prostate Cancer Tumors More Than 50% Press Release CZ BioMed Corp. Announces Successful Reduction of Prostate Cancer Tumors More Than 50% Using PRO-RVLYSIS(R) TAMPA, FL, August 26, 2013 – CZ … Continue reading
Posted in Prostate Cancer
Leave a comment
Oncolytic Virus Success Treating Colon Cancer
Oncolytic Virus “Respiratory Syncytial Virus” (RSV) Genetically Engineered to Treat Various Cancers Shows Stunning Results in Treating Colon Cancer Press Release – November 11, 2015 CZ BioMed Corp. Announces 2.5 Year Survival of Stage 4 Colon Cancer Patient. Cancer Free … Continue reading
Posted in Colon Cancer
Leave a comment
